Home | Back to newsletter main page
 |
|
April 26, 2010 |
|
MESSAGE FROM THE DIRECTORNeal Meropol, MD: Appointment as Chief, Division of Hematology-Oncology, Department of Medicine, University Hospitals Case Medical CenterPlease join me in congratulating Dr. Neal Meropol, who will remain as Associate Director for Clinical Research in the Case Comprehensive Cancer Center, in his new position as Chief, Division of Hematology-Oncology, Department of Medicine, University Hospitals Case Medical Center. This joint activity will enhance Neal's ability to coordinate clinical trials and clinical-translational research within the Division and the Cancer Center. In many ways, joining these activities together complements Neal's skills managing people and projects and his advocacy for high quality clinical trials research. Please also see the official announcement of Neal's appointment from Department of Medicine Chairman, Dr. Richard Walsh. Stan Gerson, MD CASE CCC IN THE NEWSCleveland Clinic Gets $2M to Expand Cancer Research Facilities NCI ARRA NEWS– Stimulus Funding Expands Opportunities to Enhance Cancer Research and Care at Community HospitalsThe National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is using $80 million from the American Recovery and Reinvestment Act (ARRA) to expand research benefiting patients at the 16 member hospitals of the NCI Community Cancer Centers Program (NCCCP) and to add 14 new hospitals to the current network. The expansion uses approximately $40 million of ARRA funds to support additional research opportunities within the original network of 16 NCCCP sites and another $40 million of ARRA funds to expand the network to include 14 new community cancer centers, for a total of 30 sites in 22 states. RACE FOR THE PLACE– Join Our TeamCome walk/run with us at the Race for the Place, an event to support the Gathering Place on Sunday, June 6 at Beachwood Place Mall. Registration opens at 7:30 am; race begins with the Survivor Ceremony at 9 am. Email gillian.irwin@case.edu for more information. NCI CANCER BULLETINFeatured Article Cancer Research Highlights Director's Update CALL FOR ABSTRACTS– Cancer–Related ResearchThe Case CCC Retreat will feature a poster presentation session the evening of July 9. All graduate students, postdocs and fellows conducting cancer research are invited to submit abstracts. The Retreat Program Committee will review abstracts based on the relationship to cancer, novelty, significance of findings, and clarity. Monetary prizes will be awarded. More information is available on the Call for Abstracts page. Deadline to submit abstracts to cancer@case.edu is Friday, May 21 at 5 pm. KUDOSHorst von Recum, PhD was recently awarded a National Science Foundation Career Grant: Research and Educational Program in Affinity-Based Drug Delivery. CALL FOR APPLICATIONS– Cancer Research Training AwardThe NCI is pleased to request applications from qualified candidates for a Cancer Research Training Award (CRTA). The CRTA provides an outstanding opportunity for an individual with a strong interest in understanding how cancer care and cancer control activities influence patterns of care and trends in cancer, specifically in the fields of cancer screening and the use of biomarkers in population-based research. The CRTA appointment is a one- or two-year position with the Applied Research Program, Division of Cancer Control and Population Sciences of the NCI. This position provides an exciting and unique opportunity to work with leaders in the fields of diet, weight, and physical activity related to cancer and other chronic diseases. The position will allow contact with a large number of scientists representing disciplines of epidemiology, nutritionists, assessment, clinicians, policy researchers, and other cross-cutting arenas of application. The position is opened until filled. MARK YOUR CALENDARS– Women's Cancer: Screening and Prevention in 2010Registration is open for the Case CCC Symposium, Women's Cancer: Screening and Prevention in 2010, May 7 at the Hilton Cleveland East in Beachwood. Course Overview: Early detection of cancer saves lives. Controversy exists regarding guidelines for cancer screening in women. Mammograms are not consistently obtained and women do not participate in colon cancer screening as frequently as men. Educating practitioners to the benefits of breast, cervical, endometrial, and colorectal cancer screening could help promote health practices. The indications for genetic testing for breast and ovarian cancer susceptibility will be discussed. While practitioners generally understand the harms and benefits of postmenopausal hormone replacement therapy, the specific outcomes with respect to breast and uterine cancer merit further exploration. Discussion of health choices (weight-reduction surgery, prophylactic mastectomy, smoking cessation) and their role in cancer prevention will aid practitioners in guiding patients. CME credits are available. FUNDING OPPORTUNITY– Ovarian Cancer Research FundThe Ovarian Cancer Research Fund is accepting applications for the following opportunities: Program Project Development Grants: provide funds for ovarian cancer research projects that may involve several investigators within one institution or collaborations between groups in multiple institutions. Liz Tilberis Scholars awards: are for junior investigators in their first academic faculty appointment. This award is open to physician-scientists (Gynecologic Oncology, Medical Oncology) and PhD scientists. Ovarian Cancer Research Training Programs of Excellence grant: funds post-doctoral trainees (Gynecologic Oncology or Medical Oncology fellows or PhDs) who are working in established ovarian cancer research groups. Deadline: June 25 FUNDING OPPORTUNITY– Damon Runyon-Rachleff Innovation AwardThe Damon Runyon-Rachleff Innovation Award provides support for the next generation of exceptionally creative thinkers with "high risk/high reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis and treatment of cancer. This award is specifically designed to provide funding for extraordinary early career researchers who have an innovative, new idea but lack sufficient preliminary data to obtain traditional funding. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. Eligible applicants (including non-U.S. citizens) must be conducting independent research at a U.S. institution. Institutional nominations are not required and there is no limit to the number of applications that can be received from a particular institution. Basic and translational/clinical projects will be considered and individuals with a background in multiple disciplines are especially encouraged to apply. Pre-Proposal Deadline: June 1 |
EVENTS**All events are open to anyone interested in attending April 26Case CCC Special Seminar Sequencing Data Interest Group (SDIG) Meeting April 27Taussig Cancer Institute Core Curriculum Series THOR Translational Talk April 28Grand Rounds canceled Emerging Technologies in Biomedical Research Pathology Dissertation Defense Emerging Technologies in Biomedical Research April 29Taussig Cancer Institute Core Curriculum Series Neurosciences Seminar Aging-Cancer-Energetics Seminar Zella Hall Lecture April 30Taussig Cancer Institute Grand Rounds Hem/Onc Fellows Seminar Mt. Sinai Sidney H. Sachs, MD Surgical Oncology Lectureship Cancer Center Research in Progress Seminar more UPCOMING CANCER CENTER SYMPOSIUMS & EVENTSCell Biology Seminar Case CCC Scientific Retreat ADDITIONAL UPCOMING SEMINARS & EVENTSMidwest Blood Club Symposium Business Education Course: "The Business of Regenerative Medicine: From Stem Cells to the Market Place" Advanced Training Institute on Health Behavior Theory International Symposium on Breast Cancer Prevention: Nutrition, Communication and Public Policy |
FACULTY CANDIDATE SEARCH– Associate Director for Basic ResearchThe Case CCC is currently accepting applications for the position of Associate Director for Basic Research. As we continue our search, we ask that people in the Cancer Center community encourage any qualified candidate to apply for the position. If you would like to nominate someone for the position, please contact Tracy Rehl (tracy.rehl@case.edu). |
CASE CCC ON FACEBOOK AND LINKEDIN– Join Us!We are always trying to foster communication and collaboration across the cancer center community any way that we can. The Case CCC has set up a page on Facebook and LinkedIn, so please become a fan of us on Facebook or join our group on LinkedIn, and encourage others to do so as well. Please help us spread the word. We encourage you to post events, relevant news articles, items of discussion, etc… Your feedback is appreciated! |
PREVIOUSLY ANNOUNCED OPPORTUNITIES |
|
|
DOD NFRP Clinical Trial Award |
DOD PCRP Health Disparity Research Award |
NIH Bulletin – Notices and Funding OpportunitiesRequest for Information (RFI): Priorities for the NIH Adherence Research Network (NOT-OD-10-078) Research on Malignancies in the Context of HIV/AIDS (R21)(PA-07-454) Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R01) (PA-08-243) Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R21) (PA-08-244) |
|
| Produced by: Gillian Irwin Todd 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
| |